Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
National Service Frameworks (NSF)
Standards set by the NHS that define how particular healthcare services should be performed, with an aim to provide clear quality requirements and to offer support to organisations to help achieve these requirements. These requirements are founded on the premium available evidence of what treatments work most effectively for patients.
See also:
National Health Service (NHS)
NHS Executive
Health Care Financing Administration (HCFA) (US)
Related terms
Primary care, Preferred provider organisation (PPO), American Medical Association (AMA), Food And Drug Administration (FDA), Acute care, Concordance, Health economics, European Federation of Pharmaceutical Industries (EFPIA), Defined daily dose (DDD), Health Care Financing Administration (HCFA) (US) , NHS Executive, Morbidity, Health-related Quality of QOL, General practitioner (GP), Foundation Trust (FT),
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- BMS and Century Therapeutics agree on deal potentially worth over $3bn
- Live Webinar: Measuring Vital Health Indicators Through Your Camera
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
- Live Webinar: Expanding Access to High-Quality Healthcare
- Vir Biotech launches new research programme for HIV and malaria prevention
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Why pharma must get smart in its approach to customer engagement
- NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- BMS and Century Therapeutics agree on deal potentially worth over $3bn
- FDA nod for Janssen schizophrenia treatment Invega Hafyera
